A psychopharmacological perspective of cognitive functions. II. Specific pharmacologic agents.
In this article we review the effects of specific drugs or neurotransmitter systems on cognitive functions. While much of what we know about drugs' effects on memory is derived from animal experiments, this review focuses on studies relevant to human clinical conditions. We conclude with a speculative analysis or taxonomy of the pharmacology of memory which broadly highlights the utility of viewing memory as being comprised of several differentiated processes.
O M
OM
Wolkowitz
J R
JR
Tinklenberg
H
H
Weingartner
D000305:Adrenal Cortex Hormones / Q000494:pharmacology; D000324:Adrenocorticotropic Hormone / Q000494:pharmacology; D001921:Brain / Q000502:physiology; D002395:Catecholamines / Q000494:pharmacology*; D000697:Central Nervous System Stimulants / Q000494:pharmacology; D004723:Endorphins / Q000494:pharmacology / Q000502:physiology; D006801:Humans; D008568:Memory / Q000187:drug effects* / Q000502:physiology; D009270:Naloxone / Q000494:pharmacology; D009419:Nerve Tissue Proteins / Q000096:biosynthesis; D010121:Oxytocin / Q000494:pharmacology; D010277:Parasympathomimetics / Q000494:pharmacology*; D010446:Peptide Fragments / Q000494:pharmacology; D012313:RNA / Q000096:biosynthesis; D012701:Serotonin / Q000494:pharmacology; D014665:Vasodilator Agents / Q000494:pharmacology; D014667:Vasopressins / Q000494:pharmacology; D005680:gamma-Aminobutyric Acid / Q000494:pharmacology
D000305:Adrenal Cortex Hormones; D002395:Catecholamines; D000697:Central Nervous System Stimulants; D004723:Endorphins; D009419:Nerve Tissue Proteins; D010277:Parasympathomimetics; D010446:Peptide Fragments; D014665:Vasodilator Agents; D014667:Vasopressins; D012701:Serotonin; D009270:Naloxone; D010121:Oxytocin; D005680:gamma-Aminobutyric Acid; D012313:RNA; D000324:Adrenocorticotropic Hormone